75
Participants
Start Date
November 1, 2015
Primary Completion Date
July 24, 2017
Study Completion Date
July 24, 2017
C1 esterase inhibitor [human] liquid
C1 Esterase Inhibitor \[Human\] Liquid administered Subcutaneously as specified on specified days
Placebo
Placebo
Semmelweis Egyetem, Budapest
Hospital Universitario Vall d'Hebron, Barcelona
Institute For Asthma and Allergy, Chevy Chase
Hospital Universitario La Paz, Madrid
Clinical Research of Charlotte, Charlotte
Atlanta Allergy and Asthma Clinic, Marietta
Hospital Universitario Virgen del Rocio, Seville
Clinical Research Solutions, Middleburg Heights
Bernstein Clinical Research Center Inc, Cincinnati
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Chaim Sheba Medical Center, Ramat Gan
Washington University, St Louis
Tel Aviv Sourasky Medical Center, Tel Aviv
Hämophilie Zentrum Rhein Main GmbH, Mörfelden-Walldorf
Allergy Clinic of Tulsa, Tulsa
AARA Research Center, Dallas
IMMUNOe Research Centers, Centennial
Asthma and Allergy Associates PC, Colorado Springs
Medical Research of Arizona, Scottsdale
AIRE Medical of Los Angeles, Santa Monica
Bay Area Allergy, Walnut Creek
Premier Clinical Research, Spokane
MediQuest Clinical Research Center, Târgu Mureş
Allergy Asthma and Immunology, Fair Lawn
Allergy Treatment Center of New Jersey, Iselin
McMaster University Medical Center, Hamilton
Ottawa Allergy Research Corporation, Ottawa
Lead Sponsor
Shire
INDUSTRY